MedTrace Logo

Integrating HCV and HIV Screening During the Era of HIV Antigen Testing

NCT02869776 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-12-11

No results posted yet for this study

Summary

The objective of this proposal is to develop an optimal testing strategy for HCV and HIV in high prevalence settings, such as detoxification centers with a large proportion of young injection drug users. The latest venipuncture testing will be compared to rapid finger stick testing for HCV and HIV. Outcomes for each strategy among individuals admitted at a short-term drug detoxification center will be determined.

Conditions

  • HIV
  • Hepatitis C

Interventions

BEHAVIORAL

Questionnaire

Behavioral questionnaires

PROCEDURE

Rapid finger stick

HIV and HCV testing through rapid finger stick

PROCEDURE

Venipuncture

HIV and HCV testing through venipuncture

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Sabrina Assoumou, MD, MPH · Boston Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-07-26
Completion
2017-07-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02869776 on ClinicalTrials.gov